Administration of Follicle-stimulating Hormone (FSH) and Low Dose Human Chorionic Gonadotropin (hCG) for Oocyte Maturity While Decreasing hCG Exposure in In Vitro Fertilization (IVF) Cycles

PHASE3CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 20, 2018

Study Completion Date

June 20, 2018

Conditions
Infertility
Interventions
DRUG

Low dose hCG plus FSH co-trigger

Low dose hCG (1,500 IU) plus FSH (450 IU) co-trigger

DRUG

Standard dose of hCG

Standard dose of hCG (10,000 or 5,000 IU) trigger

Trial Locations (1)

94143

University of California at San Francisco, San Francisco

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ferring Pharmaceuticals

INDUSTRY

lead

University of California, San Francisco

OTHER